Skip to main content

Table 4 Vincristine predicted toxicity profile by interaction with different systems of the body

From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation

Parameters

Predicted values

Explanation

Mutagenic potential

Negative

 

Chromosomal aberration

Toxic (60%)

Predicts whether or not the compound will trigger the mutagenic chromosomal aberrations

Overall accuracy = 80%

hERG pIC50

4.62663374

Affinity to the hERG potassium channel in human expressed as pIC_50 in mol/L. RMSE/MAE = 0.55/0.43 in log units (2D and 3D)

p-Lipidosis

Negative

Qualitative estimation of causing phospholipidosis.

Overall accuracy = 96%

Liver toxicity

ALT

Yes

Elevated 94%

Predicts whether or not the compound will cause elevation in the levels of SGPT enzyme

Overall accuracy = 89%

AST

Elevated 46%

Predicts whether or not the compound will cause elevation in the levels of SGOT enzyme

Overall accuracy = 84%

ALP

Elevated 48%

Predicts whether or not the compound will cause elevation in the levels of Alkaline Phosphatase enzyme. Overall accuracy = 91%

Serum GGT

Normal

Predicts whether or not the compound will cause elevation in the levels of GGT enzyme

Overall accuracy = 94%

Serum LDH

Elevated 45%

Predicts whether or not the compound will cause elevation in the levels of LDH enzyme

Overall accuracy = 95%

Reproductive toxicity

Yes (81%)

Qualitative estimation of reproductive/developmental toxicity. Overall accuracy = 90%

Rat TD50

0.271373

TD50 for rat carcinogenicity (mg/kg/day in oral dose) over a standard lifetime. RMSE/MAE = 0.54/0.42 (2D) and 0.52/0.43 (3D) in log units